By Editor , 4 September 2026
UB Deploys 8 Electric Buses, Cutting Fleet Emissions 55.6%

Buffalo, N.Y. – September 04, 2026 -- The University at Buffalo has put eight new 40-foot battery-electric transit buses into service, marking the first phase of a diesel-to-electric transition for its Stampede fleet, which carries approximately 16,000 passengers daily.

By Editor , 3 September 2026
Jazz's Ziihera Shows Significant Survival Edge Over Trastuzumab in GEA Trial

Dublin – September 03, 2026 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that Ziihera (zanidatamab-hrii) plus chemotherapy achieved a statistically significant and clinically meaningful overall survival benefit over trastuzumab plus chemotherapy in first-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma (GEA), based on a second interim analysis of the Phase 3 HERIZON-GEA-01 trial.

By Editor , 3 September 2026
FaceTec's UR Codes Now Deployed by US Sheriff's Offices, Project Lifesaver

Summerlin, Nev. – September 03, 2026 -- FaceTec, Inc. has released its UR® Codes August 2026 Update, detailing three law-enforcement and public-safety organizations now running the biometric identity credential in live deployments across the United States.

Albany County deputies gain instant cross-jurisdictional ID verification

The Albany County Sheriff's Office has upgraded standard Deputy ID cards with UR Codes, allowing partner agencies or citizens to instantly verify a deputy's identity and blocking use of lost, stolen or counterfeit credentials.

By Editor , 3 September 2026
Summit Midstream Greenlights $100M Double E Pipeline Expansion

Houston – September 03, 2026 -- Summit Midstream Corporation (NYSE: SMC) has reached a final investment decision on a mainline compression expansion for its Double E Pipeline, backed by a new 200 MMcf/d take-or-pay agreement with an investment-grade shipper that lifts total contracted firm capacity on the system to approximately 2.2 Bcf/d.

By Editor , 3 September 2026
Lilly's Taltz-Zepbound Combo Sustains Gains at 52 Weeks

INDIANAPOLIS – September 03, 2026 -- Eli Lilly and Company reported that combining Taltz (ixekizumab) with Zepbound (tirzepatide) sustained or deepened efficacy at 52 weeks in patients with psoriatic disease and obesity, building on statistically superior results already seen at Week 36 versus Taltz alone.

By Editor , 3 September 2026
Jazz's Ziihera Shows Significant Survival Edge Over Trastuzumab in GEA Trial

Dublin – September 03, 2026 -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) reported that Ziihera (zanidatamab-hrii) combined with chemotherapy produced a statistically significant and clinically meaningful overall survival (OS) benefit versus trastuzumab plus chemotherapy in a second interim analysis of the Phase 3 HERIZON-GEA-01 trial in first-line HER2-positive gastroesophageal adenocarcinoma (GEA).

By Editor , 3 September 2026
PVA Gathers 400+ Clinicians in Las Vegas for SCI/MS/ALS Care Summit

Las Vegas – September 03, 2026 -- Paralyzed Veterans of America (PVA) opened its 2026 Healthcare Summit + Expo at the Horseshoe Hotel, drawing more than 400 healthcare professionals to advance clinical care for spinal cord injury, MS, and ALS. The event runs through September 2 and features 110 speakers and 60 exhibitors, with remarks from Department of Veterans Affairs Secretary Doug Collins.

By Editor , 3 September 2026
NPC Calls for National Program to Map US Subsurface Resources

WASHINGTON – September 03, 2026 -- The National Petroleum Council (NPC) has issued nine recommendations urging Congress and federal agencies to launch a coordinated national program to assess America's subsurface energy and mineral resources, warning that over 80% of the country's energy needs depend on assets that remain largely unmapped for decades.